No article text was recorded for this version.
metabolic-immune crosstalk
Version 1 of 153 papers66 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma
- Blog: MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization
- Blog: Glycolytic regulatory enzyme PFKFB3 as a prognostic and tumor microenvironment biomarker in human cancers
- Blog: Histone lactylation-driven B7-H3 expression promotes tumor immune evasion
- Blog: Fumarate Hydratase Enhances the Therapeutic Effect of PD-1 Antibody in Colorectal Cancer by Regulating PCSK9
- Blog: Comprehensive Analysis of Glycolysis-Related Genes for Prognosis, Immune Features, and Candidate Drug Development in Colon Cancer
- Blog: Spermidine potentiates anti-tumor immune responses and immunotherapy sensitivity in breast cancer
- Blog: PKN2 enhances the immunosuppressive activity of polymorphonuclear myeloid-derived suppressor cells in esophageal carcinoma by mediating fatty acid oxidation
- Blog: Glycolysis- and immune-related novel prognostic biomarkers of Ewing's sarcoma: glucuronic acid epimerase and triosephosphate isomerase 1
- Blog: Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer
- Blog: An extensive bioinformatics study on the role of mitochondrial solute carrier family 25 in PC and its mechanism behind affecting immune infiltration and tumor energy metabolism
- Blog: Pan-cancer analysis predicts MBOAT2 as a potential new ferroptosis related gene immune checkpoint
- Blog: GLUT3 as an Intersection of Glycerophospholipid Metabolism and the Innate Immune Response to Candida albicans
- Blog: Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma
- Blog: Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis
- Blog: An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
- Blog: Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity
- Blog: Sialic acid metabolism-based classification reveals novel metabolic subtypes with distinct characteristics of tumor microenvironment and clinical outcomes in gastric cancer
- Blog: Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinoma
- Blog: Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
- Blog: BLCA prognostic model creation and validation based on immune gene-metabolic gene combination
- Blog: A chemotherapy response prediction model derived from tumor-promoting B and Tregs and proinflammatory macrophages in HGSOC
- Blog: AMPK-mTOR pathway modulates glycolysis reprogramming in unexplained recurrent spontaneous abortion
- Blog: Zonated Copper‐Driven Breast Cancer Progression Countered by a Copper‐Depleting Nanoagent for Immune and Metabolic Reprogramming
- Blog: Impact of NDUFAF6 on breast cancer prognosis: linking mitochondrial regulation to immune response and PD-L1 expression
- Blog: Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients
- Blog: GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration
- Blog: Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma
- Blog: SLC2A3 promotes head and neck squamous cancer developing through negatively regulating CD8+ T cell in tumor microenvironment
- Blog: Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
- Blog: IDDF2020-ABS-0201 Targeting hepatoma-intrinsic pparγ signaling overcomes immune checkpoint therapy resistance by inflaming the tumor microenvironment
- Blog: The Metabolic Regulation of the NKG2D-Positive NK and T Cells and Their Role in Disease Progression
- Blog: Construction of a novel prognostic model for gastric cancer based on pharmacokinetics-related genes and comprehensive prognostic analysis
- Blog: The Role of Amino Acid Metabolism of Tumor Associated Macrophages in the Development of Colorectal Cancer
- Blog: Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis
- Blog: A Novel Risk Score Model of Lactate Metabolism for Predicting over Survival and Immune Signature in Lung Adenocarcinoma
- Blog: A Metabolism-Related Gene Signature Predicts the Prognosis of Breast Cancer Patients: Combined Analysis of High-Throughput Sequencing and Gene Chip Data Sets
- Blog: Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion
- Blog: GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer
- Blog: Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer
- Blog: Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis
- Blog: Aquaglyceroporin-7 ameliorates sorafenib resistance and immune evasion in hepatocellular carcinoma through inhibition of lipid accumulation
- Blog: Clinical implications of morular metaplasia in fertility-preserving treatment for atypical endometrial hyperplasia and early endometrial carcinoma patients
- Blog: Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer.
- Blog: A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma
- Blog: Comprehensive analyses of fatty acid metabolism-related lncRNA for ovarian cancer patients
- Blog: Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice
- Blog: Integrated single-cell and bulk RNA sequencing analysis reveals ACACA as a potential prognostic and immunotherapeutic biomarker across cancers
- Blog: Tumor suppressing function of SLC16A7 in bladder cancer and its pan-cancer analysis
- Blog: Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy
- Blog: PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
- Blog: 1042 The dual function of the adenosine pathway in the liposarcoma tumor microenvironment
- Blog: Multiplexed non-invasive tumor imaging of glucose metabolism and receptor-ligand engagement using dark quencher FRET acceptor
History & citation
Current · Permanent link
- Metabolic Reprogramming of the Tumor Immune Microenvironment merged into this direction (55% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_metabolic_immune_crosstalk_f2c76efa,
title = {metabolic-immune crosstalk},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/metabolic-immune-crosstalk/rdr_f2c76efa8bfb481da6848fa3fe2490df},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-22},
}This exact version (version 1, frozen text):
@misc{lacuna_metabolic_immune_crosstalk_f2c76efa_v1,
title = {metabolic-immune crosstalk},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/metabolic-immune-crosstalk/rdr_f2c76efa8bfb481da6848fa3fe2490df/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-22},
}